Peggy Verdood

434 total citations
18 papers, 357 citations indexed

About

Peggy Verdood is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Peggy Verdood has authored 18 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Peggy Verdood's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Immune Cell Function and Interaction (3 papers). Peggy Verdood is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Immune Cell Function and Interaction (3 papers). Peggy Verdood collaborates with scholars based in Belgium, United States and Japan. Peggy Verdood's co-authors include Ron Kooijman, Sarah Gerlo, E. L. Hooghe‐Peters, Elisabeth L. Hooghe‐Peters, Robert Hooghe, Zeynep Doğusan, Birgit Gellersen, Johan Schiettecatte, Brigitte Velkeniers and Jean De Schepper and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Biochemical Journal.

In The Last Decade

Peggy Verdood

18 papers receiving 341 citations

Peers

Peggy Verdood
Babak Dehghani United States
Alyson B. Scoltock United States
F. Homo France
Farhad Dehkhoda Australia
Alicia Roldán Argentina
Peggy Verdood
Citations per year, relative to Peggy Verdood Peggy Verdood (= 1×) peers Alberto Carbia Nagashima

Countries citing papers authored by Peggy Verdood

Since Specialization
Citations

This map shows the geographic impact of Peggy Verdood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Verdood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Verdood more than expected).

Fields of papers citing papers by Peggy Verdood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Verdood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Verdood. The network helps show where Peggy Verdood may publish in the future.

Co-authorship network of co-authors of Peggy Verdood

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Verdood. A scholar is included among the top collaborators of Peggy Verdood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Verdood. Peggy Verdood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Geyter, Deborah De, et al.. (2017). Post-stroke treatment with 17β-estradiol exerts neuroprotective effects in both normotensive and hypertensive rats. Neuroscience. 348. 335–345. 5 indexed citations
3.
Himpe, Eddy, Saranyapin Potikanond, Peggy Verdood, & Ron Kooijman. (2011). Attenuation of IGF-I receptor signaling inhibits serum-induced proliferation of prostate cancer cells. Growth Hormone & IGF Research. 21(5). 252–259. 1 indexed citations
4.
Gerlo, Sarah, Peggy Verdood, & Ron Kooijman. (2010). Modulation of Cytokine Production by Cyclic Adenosine Monophosphate Analogs in Human Leukocytes. Journal of Interferon & Cytokine Research. 30(12). 883–891. 17 indexed citations
5.
Gerlo, Sarah, Peggy Verdood, & Ron Kooijman. (2005). Tumor necrosis factor-α activates the extrapituitary PRL promoter in myeloid leukemic cells. Journal of Neuroimmunology. 172(1-2). 206–210. 9 indexed citations
6.
Gerlo, Sarah, Peggy Verdood, Elisabeth L. Hooghe‐Peters, & Ron Kooijman. (2005). Multiple, PKA-dependent and PKA-independent, signals are involved in cAMP-induced PRL expression in the eosinophilic cell line Eol-1. Cellular Signalling. 17(7). 901–909. 19 indexed citations
7.
Gerlo, Sarah, Peggy Verdood, E. L. Hooghe‐Peters, & Ron Kooijman. (2005). Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells. Cellular and Molecular Life Sciences. 63(1). 92–9. 26 indexed citations
8.
Theunissen, Caroline, et al.. (2005). MACROPROLACTINEMIA: CLINICAL SIGNIFICANCE AND CHARACTERIZATION OF THE CONDITION. Acta Clinica Belgica. 60(4). 190–197. 9 indexed citations
9.
Gerlo, Sarah, Peggy Verdood, Elisabeth L. Hooghe‐Peters, & Ron Kooijman. (2005). Modulation of prolactin expression in human T lymphocytes by cytokines. Journal of Neuroimmunology. 162(1-2). 190–193. 34 indexed citations
10.
Gerlo, Sarah, Peggy Verdood, Birgit Gellersen, Elisabeth L. Hooghe‐Peters, & Ron Kooijman. (2004). Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5′-Monophosphate-Mediated Signaling Pathways. The Journal of Immunology. 173(10). 5952–5962. 41 indexed citations
11.
Gerlo, Sarah, et al.. (2003). Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells. Journal of Neuroimmunology. 135(1-2). 107–116. 16 indexed citations
12.
Schepper, Jean De, Johan Schiettecatte, Brigitte Velkeniers, et al.. (2003). Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology. 149(3). 201–207. 57 indexed citations
13.
Doğusan, Zeynep, Robert Hooghe, Peggy Verdood, & E. L. Hooghe‐Peters. (2001). Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. Journal of Neuroimmunology. 120(1-2). 58–66. 62 indexed citations
14.
Doğusan, Zeynep, et al.. (2000). Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells.. PubMed. 11(3). 435–42. 16 indexed citations
15.
Rajas, Fabienne, Mireille Delhase, Miguel de la Hoya, et al.. (1998). Nuclear factor 1 regulates the distal silencer of the human PIT1/GHF1 gene. Biochemical Journal. 333(1). 77–84. 17 indexed citations
16.
Delhase, Mireille, Fabienne Rajas, Peggy Verdood, et al.. (1995). Prolactin and growth hormone mRNA and protein characterization in SMtTW rat pituitary tumours. Journal of Molecular Endocrinology. 15(3). 233–243. 5 indexed citations
17.
Raschellà, Giuseppe, G. Smets, Annelies Claeys, et al.. (1989). Transcriptional pattern of 21-hydroxylase gene (P-450C21) during embryonic development, before, and after birth in mice as determined by in situ hybridization.. Journal of Histochemistry & Cytochemistry. 37(5). 751–756. 6 indexed citations
18.
Vanhaelst, L., et al.. (1975). Gel Filtration Profile of Circulating Immunoreactive Thyrotropin and Subunits of Myxedematous Sera. The Journal of Clinical Endocrinology & Metabolism. 41(3). 575–580. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026